We validated the predictive value and diagnostic value of JMJD4 in ccRCC patients, as well as the effect of JMJD4 on promoting the invasion and proliferation of ccRCC cells. This evidence concerns the gene JMJD4 and nonpapillary renal cell carcinoma.